Surgery Partners, Inc.
SGRY
Positions held
Your positionsSGRY isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Surgery Partners operates in a growing healthcare sector, focusing on outpatient surgery, which is increasingly preferred for its cost-effectiveness and convenience.
- Revenue increased by 5% from the prior quarter, reaching $849 million.
- Gross margin improved to 22.4%, up from 19.8% in the previous quarter.
- The company has a high debt-to-equity ratio of 117.26, indicating potential financial risk.
- Net income for the most recent quarter was -$15 million, continuing a trend of losses.
- The stock has a 'Strong Sell' signal with a score of -15.00, indicating bearish market sentiment.
Fundamentals
| Market cap | $1.79B | Enterprise value | $7.42B | Trailing P/E | — | Forward P/E | 48.71 |
| PEG | — | Price / book | 1.06 | Beta | 1.91 | Dividend yield | 0.00% |
| Revenue growth | 2.7% | Earnings growth | — | Gross margin | 22.5% | Operating margin | 13.7% |
| Profit margin | -2.6% | ROE | 2.3% | ROA | 3.7% | Debt / equity | 1.17 |
| Current ratio | 1.95 | Free cash flow | $183.56M | Analyst recommendation | buy | Mean target | $18.82 |
| 52w high | $23.44 | 52w low | $11.41 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $849M | $811M | $885M | $822M | $826M | — |
| Op margin | 13.7% | 10.4% | 14.1% | 16.4% | 14.7% | — |
| Net income | -$15.0M | -$35.9M | -$15.0M | -$22.7M | -$2.5M | — |
| Gross margin | 22.4% | 19.8% | 24.0% | 23.8% | 23.7% | — |
| Gross profit | $190M | $160M | $212M | $195M | $196M | — |
| Operating income | $117M | $84.1M | $125M | $135M | $121M | — |
- Revenue +5% vs prior quarter ($849M vs $811M).
- Gross margin 22.4% (was 19.8% prior quarter).
- Operating margin expanded to 13.7%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.3B | $3.1B | $2.7B | $2.5B | — |
| Op margin | 14.2% | 14.6% | 14.9% | 14.1% | — |
| Net income | -$77.9M | -$168M | -$11.9M | -$54.6M | — |
| Gross margin | 23.1% | 23.9% | 23.6% | 22.6% | — |
| Gross profit | $765M | $746M | $648M | $575M | — |
| Operating income | $471M | $454M | $409M | $358M | — |
Headlines — watch
• [WARN · legal] 3 Cash-Producing Stocks Walking a Fine Line
News
2026-09-30 · Surgery Partners' Idaho Falls Sales Tightens Core Strategy, RBC Says
2026-09-23 · Surgery Partners (SGRY): Buy, Sell, or Hold Post Q2 Earnings?
2026-09-23 · Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?
2026-09-18 · Can Intuitive Surgical Make Up For A Lower Price Per Surgery?
2026-09-17 · Surgery Partners Lowers 2026 Revenue Guidance; Completes $797 Million Sale of Idaho Falls Facilities
2026-09-03 · Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
2026-08-27 · 3 Cash-Producing Stocks Walking a Fine Line
2026-08-20 · Surgery Partners (SGRY) Stock May Be Undervalued After Q2 Earnings Beat
2026-08-17 · Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript
2026-08-17 · Community Health Trades at a Deep Discount to Peers: Hold or Fold?
Price (daily)
Full chart · RSI · MACD · patterns